Thompson Davis & Co’s Halozyme HALO Stock Holding History

Thompson Davis & Co’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	$2K	Hold	125	–	–	﹤0.01%	663
2018 Q2	$2K	Sell	125 -250	-67%	-$4.73K	﹤0.01%	611
2018 Q1	$7K	Hold	375	–	–	0.02%	444
2017 Q4	$8K	Buy	375 +250	+200%	+$4.6K	0.02%	451
2017 Q3	$2K	Buy	+125	New	+$1.69K	﹤0.01%	993
2014 Q2	–	Sell	-500	Closed	-$6K	–	793
2014 Q1	$6K	Hold	500	–	–	0.01%	598
2013 Q4	$7K	Buy	+500	New	+$6.43K	0.01%	513

Other funds holding HALO

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

PAMU

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Thompson Davis & Co's HALO Position: Q3 2018 in Review

Thompson Davis & Co held its Halozyme (HALO) position steady in Q3 2018 at 125 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #663.

Thompson Davis & Co first reported a position in HALO in Q4 2013 and has held it in 7 quarters since. The position peaked at $8K in Q4 2017. 193 funds tracked by Wall St. Rank hold HALO as of Q3 2018.

Thompson Davis & Co held 125 shares of Halozyme worth $2K as of Q3 2018.
Thompson Davis & Co left its Halozyme share count unchanged in Q3 2018.
Halozyme made up ﹤0.01% of Thompson Davis & Co's portfolio in Q3 2018, its #663 holding.
Thompson Davis & Co first reported a position in Halozyme in Q4 2013 and has held it in 7 quarters since.
Thompson Davis & Co's Halozyme position peaked at $8K in Q4 2017.
193 funds tracked by Wall St. Rank held Halozyme as of Q3 2018.

Based on Thompson Davis & Co's 13F filing for Q3 2018, filed 14 Nov 2018.